Active Pharmaceutical Ingredients. Devel
โ Stanley H. Nusim
๐ Library
๐
2005
๐ Marcel Dekker
๐ English
โฆ LIBER โฆ
๐
Active Pharmaceutical Ingredients Development Manufacturing and Regulation
โ Scribed by Stanley Nusim
- Publisher
- Informa Healthcare
- Year
- 2005
- Tongue
- English
- Leaves
- 341
- Series
- Drugs and the Pharmaceutical Sciences
- Category
- Library
โฌ Acquire This Volume
No coin nor oath required. For personal study only.
โฆ Synopsis
Focusing on the three most critical components that successfully bring an API to market-process development, manufacturing, and governmental regulation and approval-this reference serves as a step-by-step guide to the planning and clear understanding of the bulk manufacturing of APIs. This guide offers current and timely discussions of the process development cycle, design engineering, the approval process, quality control and assurance, and validation, as well as plant manufacturing activities including materials management, maintenance, and safety.
๐ SIMILAR VOLUMES
Active pharmaceutical ingredients : deve
โ Stanley Nusim
๐ Library
๐
2010
๐ Informa Healthcare
๐ English
Active Pharmaceutical Ingredients. Deve
โ Stanley H. Nusim
๐ Library
๐
2005
๐ CRC Press
๐ English
This guide offers current and timely discussions of the process development cycle, design engineering, the approval process, quality control and assurance, and validation, as well as plant manufacturing activities including materials management, maintenance, and safety.
Active Pharmaceutical Ingredients - Deve
โ S. Nussim(ed)
๐ Library
๐
2005
๐ English
Active Pharmaceutical Ingredients - Deve
โ S. Nusim
๐ Library
๐
2005
๐ Taylor and Francis
๐ English
Active Pharmaceutical Ingredient Manufac
โ Malhotra G.K.
๐ Library
๐
2022
๐ Walter de Gruyter
๐ English
The book reviews the history of current brand and generic business in pharmaceuticals manufacturing practices. Based on examples, the reader can interpolate, extrapolate and exploit mutual behavior (physical and chemical properties) of chemicals to design and commercialize processes that fulfi ll th